ATE71301T1 - Verwendung von azidothymidin zur behandlung der psoriasis. - Google Patents

Verwendung von azidothymidin zur behandlung der psoriasis.

Info

Publication number
ATE71301T1
ATE71301T1 AT88109039T AT88109039T ATE71301T1 AT E71301 T1 ATE71301 T1 AT E71301T1 AT 88109039 T AT88109039 T AT 88109039T AT 88109039 T AT88109039 T AT 88109039T AT E71301 T1 ATE71301 T1 AT E71301T1
Authority
AT
Austria
Prior art keywords
azidothymidine
psoriasis
dosage forms
disclosed
treatment
Prior art date
Application number
AT88109039T
Other languages
English (en)
Inventor
Madeleine Duvic
Gary W Brewton
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE71301T1 publication Critical patent/ATE71301T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT88109039T 1987-06-09 1988-06-07 Verwendung von azidothymidin zur behandlung der psoriasis. ATE71301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/059,907 US4804651A (en) 1987-06-09 1987-06-09 Methods and compositions for the treatment of psoriasis
EP88109039A EP0301206B1 (de) 1987-06-09 1988-06-07 Verwendung von Azidothymidin zur Behandlung der Psoriasis

Publications (1)

Publication Number Publication Date
ATE71301T1 true ATE71301T1 (de) 1992-01-15

Family

ID=22026060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88109039T ATE71301T1 (de) 1987-06-09 1988-06-07 Verwendung von azidothymidin zur behandlung der psoriasis.

Country Status (15)

Country Link
US (1) US4804651A (de)
EP (1) EP0301206B1 (de)
JP (1) JP2510675B2 (de)
KR (1) KR950014447B1 (de)
AT (1) ATE71301T1 (de)
AU (1) AU606423B2 (de)
DE (1) DE3867560D1 (de)
DK (1) DK310188A (de)
ES (1) ES2038716T3 (de)
GR (1) GR3003785T3 (de)
HU (1) HU200693B (de)
IE (1) IE61091B1 (de)
MY (1) MY103734A (de)
PH (1) PH26517A (de)
ZA (1) ZA884056B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
WO1989012067A1 (en) * 1988-05-27 1989-12-14 The United States Of America, As Represented By Th Compositions having use as treatment of psoriasis and neuropsychiatric deficits
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 3’‐アジド‐3’デオキシチミジンを有効成分とする経皮投与製剤用組成物
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
CA2122585A1 (en) * 1991-12-13 1993-06-24 Martin J. Griffin Transdermal azidothymidine
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US5973010A (en) * 1998-05-15 1999-10-26 Crawford; Robert L. Composition for healing skin wounds
GR1003491B (el) * 1999-12-21 2000-11-30 Μεθοδος παρασκευης φαρμακοτεχνικου σκευασματος, αλοιφης η κρεμασκαι χρηση του στην αντιμετωπιση και θεραπεια της ψωριασεως και του εκζεματος
WO2007103687A2 (en) * 2006-03-01 2007-09-13 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199451B1 (de) * 1985-03-16 1996-03-06 The Wellcome Foundation Limited Therapeutische Nukleoside
HU199865B (en) * 1987-03-16 1990-03-28 Wellcome Found Process for production of healing nucleosides and medical compositions containing them

Also Published As

Publication number Publication date
DE3867560D1 (de) 1992-02-20
DK310188A (da) 1988-12-12
GR3003785T3 (de) 1993-03-16
IE61091B1 (en) 1994-09-21
HU200693B (en) 1990-08-28
EP0301206B1 (de) 1992-01-08
PH26517A (en) 1992-08-07
IE881708L (en) 1988-12-09
JPS6470417A (en) 1989-03-15
KR950014447B1 (ko) 1995-11-28
JP2510675B2 (ja) 1996-06-26
MY103734A (en) 1993-09-30
ES2038716T3 (es) 1995-04-01
EP0301206A3 (en) 1989-09-06
DK310188D0 (da) 1988-06-08
AU606423B2 (en) 1991-02-07
AU1751088A (en) 1988-12-15
KR890000093A (ko) 1989-03-11
EP0301206A2 (de) 1989-02-01
US4804651A (en) 1989-02-14
HUT47853A (en) 1989-04-28
ZA884056B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
US5654312A (en) Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US5098899A (en) Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US4654373A (en) Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
US4743597A (en) Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
FR2364030A1 (fr) Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
CA2120367A1 (en) Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology
EP0391905A1 (de) Hämorrhoidenzusammensetzung und sonstige zusammensetzungen sowie behandlungsverfahren.
ATE71301T1 (de) Verwendung von azidothymidin zur behandlung der psoriasis.
ES8500738A1 (es) Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel
WO1990004967A3 (de) Topische salbe
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
Hay et al. Short course ketoconazole therapy in pityriasis versicolor
RU2002121546A (ru) Вещества, предназначенные для лечения псориаза
Collier et al. Topical 5‐aminosalicylic acid: a treatment for aphthous ulcers
US4395420A (en) Method and composition for treating pruritis
US3629412A (en) Topical anti-inflammatory agent
US4038417A (en) Method for treatment of psoriasis
ES2096203T3 (es) Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen.
Lassus Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
US4751236A (en) Method for treating genital herpes
Langner et al. 13-cis-retinoic acid and tetracycline versus 13-cis-retinoic acid alone in the treatment of nodulocystic acne
Vena et al. Topical 5-fluorouracil in the treatment of discoid lupus erythematosus. Preliminary study over two years

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee